Metoprolol Succinate ER Tablets IP

Get a Price/Quote

MOQ : 100 Packs

Metoprolol Succinate ER Tablets IP Specification

Brand Name
Metoprolol Succinate ER Tablets IP

Packaging Type
Blister pack

Dosage Form
Extended Release Tablets

Origin of Medicine
India

Life Span
24 months from manufacture date

Indication
Hypertension, chronic heart failure, angina, myocardial infarction

Salt Composition
Metoprolol Succinate

Pacakaging (Quantity Per Box)
100 tablets

Drug Type
Allopathic

Ingredients
Metoprolol Succinate extended release

Physical Form
Tablets

Function
Beta blocker - lowers blood pressure, reduces cardiac workload

Recommended For
Hypertension, angina pectoris, heart failure

Dosage
As directed by physician

Dosage Guidelines
Take with or immediately after food, at the same time each day

Suitable For
Adults

Quantity
10x10 tablets per box

Storage Instructions
Store in a cool, dry place away from light

Approval
IP (Indian Pharmacopoeia) quality standard

Shape
Oval or round (depends on strength)

Side Effects
Fatigue, dizziness, slow heart rate, gastrointestinal disturbance

Color
White or off-white

Caution
Use with caution in patients with diabetes, bronchospasm, or renal impairment

Maximum Retail Price (MRP)
As printed on pack

Contraindications
Severe bradycardia, sick sinus syndrome, heart block, cardiogenic shock

Administration Route
Oral

Strengths Available
25 mg, 50 mg, 100 mg

Metoprolol Succinate ER Tablets IP Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
10 Days

Main Domestic Market
All India

About Metoprolol Succinate ER Tablets IP

Experience an enlightened approach to cardiovascular care with Metoprolol Succinate ER Tablets IP, now available at a reduced price during our exclusive sale. These grandiose, ineffable tablets-offered in 25 mg, 50 mg, and 100 mg strengths-deliver sustained efficacy against hypertension, heart failure, and angina. Each oval or round, white or off-white tablet adheres to IP quality, ensuring maximum confidence. With clear dosage guidelines and reduced reliance on frequency, this price cut provides both economic and therapeutic value without compromise for discerning adults.

Metoprolol Succinate ER Tablets IP: Surface Application, Machine Features & Advantages

Metoprolol Succinate ER Tablets IP are administered orally, with each extended-release tablet providing reliable and consistent dosing. The uniform white or off-white color and distinct tablet shapes improve ease of recognition and application. The advanced manufacturing technology ensures stable, prolonged release, offering the advantage of once-daily dosing. This not only optimizes therapeutic outcomes but also enhances patient compliance, ensuring that adults facing hypertension or cardiac challenges receive steadfast, uninterrupted health support.

Supply Valuation, Payment Terms & Dispatch Details for Metoprolol Succinate ER Tablets IP

Our tablets are dispatched promptly from trusted Indian suppliers, ensuring quick arrival at your destination. Each order undergoes detailed valuation before shipment to guarantee accurate pricing and documentation. We accept a variety of payment terms for your convenience. All shipments are FOB (Free on Board) at major Indian ports, allowing efficient export and timely global delivery. Our expansive supply ability ensures that bulk or urgent orders are accommodated without delay, supporting uninterrupted healthcare provision.

FAQ's of Metoprolol Succinate ER Tablets IP:

Q: How should Metoprolol Succinate ER Tablets IP be taken for optimal effectiveness?

A: Metoprolol Succinate ER Tablets IP should be taken with or immediately after food, at the same time each day, as directed by your physician, ensuring consistent absorption and optimal effectiveness.

Q: What strengths and packaging options are available for Metoprolol Succinate ER Tablets IP?

A: These tablets are available in strengths of 25 mg, 50 mg, and 100 mg, offered in a blister pack with 10x10 (100) tablets per box, ensuring convenience and ease of use.

Q: When should you avoid using Metoprolol Succinate ER Tablets IP?

A: You should avoid using these tablets if you have severe bradycardia, sick sinus syndrome, heart block, or cardiogenic shock. Consult your physician if you have any of these conditions.

Q: Where are Metoprolol Succinate ER Tablets IP manufactured and under what quality standard?

A: Metoprolol Succinate ER Tablets IP are manufactured in India under the strict Indian Pharmacopoeia (IP) quality standards, ensuring reliability and safety.

Q: What are the possible side effects and precautions associated with Metoprolol Succinate ER Tablets IP?

A: Common side effects include fatigue, dizziness, slow heart rate, and gastrointestinal disturbances. Use caution if you have diabetes, bronchospasm, or renal impairment, and discuss any concerns with your healthcare provider.

Q: How is the supply and shipment process for Metoprolol Succinate ER Tablets IP managed?

A: All orders are valued and processed for swift dispatching from India via FOB ports; arrival times vary by destination. Order tracking and updates ensure transparency throughout the shipping process.

Tell us about your requirement